RE:RE:RE:RE:RE:RE:RE:ONCY's pelareorep activates TiLs (CD8+ Dendritic Cells)
I am not sure how easily it will be able to enroll that many patients as there are a lot of trials out there but with the help of a hopeful partner it will be much easier as it will be promoted much more rather than onc taking the chance of going it alone. That is why even though this is not officially a phase 3 registration trial that it is important that onc has help going forward. Also one must remember that the pool according to previous onc investor presentations was about 500k persons as compared to a pool of now about 55k persons. Yes I know they are going to power the trial for hopeful AA but that is not a given as they need to have the results from the interim prove out to warrant the fda AA approval and since we are dealing with a different patient population we can only hope that the results will play out similar. Also at this point they still have to get the fda approval for the trial protocols for both the mbc and the panc trials which appear not to be until 2025 if you listen to the fireside chat. Big thing I am hoping for is onc stated that they were looking for either the required number of events or the 2 year os for the mbc and they chose the 2 year os which leads me to believe that there are possibly still patients alive but am thinking that since they chose the 2 year that this will be what they will be reporting on and even though they said they are still analyzing the data I am sure that they already know the 1 and 2 year os and can only hope that they will update past that.
Of course some of the above IMO